Megan Harlan Fleischut and Kenneth Offit
Q & A
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, March 24, 2015

Women can use the results of genetic tests to make informed decisions about ovary removal to reduce cancer risk.

Exceptional responders of new drugs in clinical trials.
Decoder
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, March 24, 2015

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Pictured: Charles Sawyers
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, March 12, 2015

Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer.

Christina Leslie and John Petrini
Announcement
By Jim Stallard, MA, Writer/Editor  |  Thursday, February 12, 2015

MSK’s Functional Genomics Initiative will enable basic scientists to take full advantage of the massive amount of data produced by tumor sequencing.

Epigenetics
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, January 30, 2015

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.

In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, January 28, 2015

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.

(From left) MSK investigators Michael Berger, José Baselga, and Maurizio Scaltriti, and graduate student Pau Castel.
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 17, 2014

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.

Pictured: William Lee, Chris Sander & Nils Weinhold
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, November 13, 2014

In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.

Gregory Riely
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, November 12, 2014

MSK lung cancer patients benefit from a powerful genomic test that looks for mutations in 341 genes to help determine the best treatment.

Cancer biologist Andrea Ventura
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 6, 2014

For the first time, Memorial Sloan Kettering scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement — a type of mutation that is common in cancers but thus far has been very difficult to study.

A student asks a question at last year’s "Major Trends” seminar.
Event
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 3, 2014

Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.

RISE Program Clinical Director Debra Mangino discusses next steps with a patient.
In the Clinic
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 31, 2014

The team of experts in our RISE Program tailor each woman’s surveillance plan based on the latest findings in breast cancer risk, prevention, and treatment.

Pictured: Jorge Reis-Filho and Britta Weigelt
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Tuesday, October 28, 2014

Genetic alterations linked to a rare salivary cancer could also shed light on more common malignancies.

DNA wrapped around histones
Decoder
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, October 14, 2014

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

Pictured: Ping Chi
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, October 9, 2014

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

Center News

Stay Informed

Get the latest information about cancer care and research every month.